SCHEMBL28575299

SCHEMBL28575299

NC(=O)Oc1nc2c(O)ccc(F)c2s1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.33
KDM4E B2RXH2 2/20 0.31
MPI P34949 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
AKR1B1 P15121 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28902824 0.77 CLK1 (0.31)
SCHEMBL27209845 0.75 PDGFRB (0.31)
SCHEMBL29005839 0.75
SCHEMBL29005840 0.73 AKR1B1 (0.30) AKR1B1
SCHEMBL29885344 0.73 PDPK1 (0.49) KDM4EMPIL3MBTL1
SCHEMBL21091402 0.73 PDPK1 (0.49) KDM4EMPIL3MBTL1
SCHEMBL28564433 0.71 PLK4 (0.30) PIM1
Bromide SCHEMBL29611625 0.71 PDPK1 (0.47) KDM4EMPIL3MBTL1
Bromide SCHEMBL21839488 0.71 PDPK1 (0.47) KDM4EMPIL3MBTL1
Bromide SCHEMBL21839487 0.70 PDPK1 (0.46) KDM4EMPIL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113637005-B KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2024-05-24 CN disclosed
CN-117820333-A KRAS G12C inhibitors 伊莱利利公司 2024-04-05 CN disclosed
CN-114828964-B KRAS G12C inhibitors 伊莱利利公司 2023-11-24 CN disclosed
CN-114828964-A KRAS G12C inhibitors 伊莱利利公司 2022-07-29 CN disclosed
CN-112805281-B KRAS G12C inhibitors 伊莱利利公司 2022-05-10 CN disclosed
CN-113637005-A KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2021-11-12 CN disclosed
CN-112805281-A KRAS G12C inhibitors 伊莱利利公司 2021-05-14 CN disclosed